Pattern of degradation of human complement fragment, C3b
Authors:
- Edith SimESEdith Sim
- Andrew B. WoodAWAndrew B. Wood
- Li-Min HsiungLHLi-Min Hsiung
- Robert B. SimRSRobert B. Sim
- 14 September 1981
- journal article
- research article
- Published by Wiley in FEBS Letters
- Vol. 132 (1) , 55-60
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors. Enhancement of antibody-mediated cellular cytotoxicity.Journal of Experimental Medicine, 1981
- Treatment of Human Complement Components C4 and C3 with Amines or Chaotropic IonsScandinavian Journal of Immunology, 1981
- Novel cleavage products of the third component of human complementMolecular Immunology, 1980
- The physiological breakdown of the third component of human complementMolecular Immunology, 1980
- The role of C4-binding protein and {beta }1H in proteolysis of C4b and C3bJournal of Experimental Medicine, 1979
- Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator.Journal of Experimental Medicine, 1978
- Mechanism of action of the C3b inactivator: Requiremen for a high molecular weight cofactor (C3b-C4bINA cofactor) and production of a new C3b derivative (C3b′)Immunochemistry, 1977
- Biosynthesis of pro-C3, a precursor of the third component of complement.Journal of Experimental Medicine, 1977
- Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.Journal of Experimental Medicine, 1977
- C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.Journal of Clinical Investigation, 1976